Key facts
- This page summarizes Daniel P. Finke's Form 4 filing for CVS HEALTH Corp (CVS).
- 2 reported transactions and 6 derivative rows are listed below.
- Accepted by SEC: 04 Apr 2023, 16:27.
Daniel P. Finke - 01 Apr 2023 Form 4 Insider Report for CVS HEALTH Corp (CVS)
- Reporting relationship
- EVP/Pres, Health Care Benefits
- Issuer ticker
- CVS
- Reported as of
- 01 Apr 2023
- Net transaction value
- +$5,229,343
- SEC form
- 4
- Accepted by SEC
- 04 Apr 2023, 16:27:10 UTC
- Prior SEC filing
- 05 Aug 2022
- Next SEC filing
- 18 May 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Daniel P. Finke
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Daniel P. Finke filed Form 4 for CVS HEALTH Corp (CVS) on 04 Apr 2023.
Change
- Previous filing in this sequence was filed on 05 Aug 2022.
- Current net transaction value: +$5,229,343.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
CVS
transaction
Common Stock
Tax liability
- Transaction value
- $286,539
- Shares
- -3,856
- Change %
- -9.9%
- Price
- $74.31
- Shares after
- 35,068
- Date
- 01 Apr 2023
- Ownership
- Direct
- Footnotes
- F1
CVS
holding
Common Stock (pep)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 3,173
- Date
- 01 Apr 2023
- Ownership
- Direct
CVS
holding
Common Stock (Restricted)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 6,107
- Date
- 01 Apr 2023
- Ownership
- Direct
CVS
holding
Stock Unit (deferred)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 3,173
- Date
- 01 Apr 2023
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
CVS
transaction
Derivative
Stock Option
Award
- Transaction value
- $5,515,883
- Shares
- +74,228
- Change %
- Price
- $74.31
- Shares after
- 74,228
- Date
- 01 Apr 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 74,228
- Exercise price
- $74.31
- Footnotes
- F7
CVS
holding
Derivative
Stock Option
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 16,161
- Date
- 01 Apr 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 16,161
- Exercise price
- $54.19
- Footnotes
- F2
CVS
holding
Derivative
Stock Option
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 27,166
- Date
- 01 Apr 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 27,166
- Exercise price
- $58.34
- Footnotes
- F3
CVS
holding
Derivative
Stock Option
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 82,066
- Date
- 01 Apr 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 82,066
- Exercise price
- $74.30
- Footnotes
- F4
CVS
holding
Derivative
Stock Option
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 19,094
- Date
- 01 Apr 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 19,094
- Exercise price
- $52.37
- Footnotes
- F5
CVS
holding
Derivative
Stock Option
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 51,975
- Date
- 01 Apr 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 51,975
- Exercise price
- $101.09
- Footnotes
- F6
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 7 footnotes
Footnote F1
Surrender of shares in payment of withholding taxes due upon the vesting and settlement of a restricted stock unit award.
Footnote F2
Option became exercisable in four equal annual installments, beginning on 4/1/2020.
Footnote F3
Option became exercisable in four equal annual installments, commencing 4/1/2021.
Footnote F4
Option became exercisable in four equal annual installments, commencing 4/1/2022.
Footnote F5
Option became exercisable in three equal annual installments, commencing 5/31/2022.
Footnote F6
Option became exercisable in four equal annual installments, commencing 4/1/2023.
Footnote F7
Option becomes exercisable in four equal annual installments, commencing 4/1/2024.